[{"address1": "900 Middlefield Road", "address2": "4th Floor", "city": "Redwood City", "state": "CA", "zip": "94063", "country": "United States", "phone": "650 980 9099", "website": "https://biomeafusion.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, a covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. The company was incorporated in 2017 and is headquartered in Redwood City, California.", "fullTimeEmployees": 107, "companyOfficers": [{"maxAge": 1, "name": "Mr. Thomas Andrew Butler", "age": 42, "title": "Co-Founder, Chairman & CEO", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 950407, "exercisedValue": 0, "unexercisedValue": 5655125}, {"maxAge": 1, "name": "Mr. Ramses M. Erdtmann", "age": 60, "title": "Co-Founder, President, COO & Director", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Franco  Valle CPA", "age": 42, "title": "CFO & Principal Accounting Officer", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 673659, "exercisedValue": 0, "unexercisedValue": 687866}, {"maxAge": 1, "name": "Dr. Juan Pablo Frias M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "totalPay": 492250, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Heow  Tan", "age": 64, "title": "Chief Technology & Quality Officer", "yearBorn": 1959, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Naomi  Cretcher", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Thorsten  Kirschberg Ph.D.", "age": 53, "title": "Executive Vice President of Chemistry", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephan  Morris M.D.", "title": "Chief Development Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ravi  Upasani", "title": "Executive Vice President of Intellectual Property", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Caroline  Perez- Dupont", "title": "Senior Vice President of Contracts", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1733011200, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 4.08, "open": 4.09, "dayLow": 3.9, "dayHigh": 4.3, "regularMarketPreviousClose": 4.08, "regularMarketOpen": 4.09, "regularMarketDayLow": 3.9, "regularMarketDayHigh": 4.3, "beta": -0.427, "forwardPE": -1.3125943, "volume": 787990, "regularMarketVolume": 787990, "averageVolume": 857560, "averageVolume10days": 1518950, "averageDailyVolume10Day": 1518950, "bid": 3.97, "ask": 4.03, "bidSize": 100, "askSize": 200, "marketCap": 144954800, "fiftyTwoWeekLow": 3.61, "fiftyTwoWeekHigh": 20.21, "fiftyDayAverage": 7.4974, "twoHundredDayAverage": 8.6667, "currency": "USD", "enterpriseValue": 74904648, "floatShares": 22455665, "sharesOutstanding": 36238700, "sharesShort": 9916793, "sharesShortPriorMonth": 8476877, "sharesShortPreviousMonthDate": 1730332800, "dateShortInterest": 1732838400, "sharesPercentSharesOut": 0.2737, "heldPercentInsiders": 0.25016, "heldPercentInstitutions": 0.64562, "shortRatio": 12.98, "shortPercentOfFloat": 0.4456, "impliedSharesOutstanding": 36238700, "bookValue": 2.096, "priceToBook": 1.908397, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -144008000, "trailingEps": -4.01, "forwardEps": -3.32, "enterpriseToEbitda": -0.501, "52WeekChange": -0.72733474, "SandP52WeekChange": 0.25891924, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "BMEA", "underlyingSymbol": "BMEA", "shortName": "Biomea Fusion, Inc.", "longName": "Biomea Fusion, Inc.", "firstTradeDateEpochUtc": 1618579800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "bc0a49f6-c4ed-3d62-b67c-2f5f0de07165", "messageBoardId": "finmb_695310535", "gmtOffSetMilliseconds": -18000000, "currentPrice": 4.0, "targetHighPrice": 128.0, "targetLowPrice": 11.0, "targetMeanPrice": 40.55556, "targetMedianPrice": 30.0, "recommendationMean": 1.77778, "recommendationKey": "buy", "numberOfAnalystOpinions": 9, "totalCash": 87952000, "totalCashPerShare": 2.427, "ebitda": -149624992, "totalDebt": 9567000, "quickRatio": 3.19, "currentRatio": 3.395, "debtToEquity": 12.593, "returnOnAssets": -0.56379, "returnOnEquity": -1.04511, "freeCashflow": -65435500, "operatingCashflow": -112727000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-28"}]